HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederik A Verburg Selected Research

N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acid

4/2017The reconstruction algorithm used for [68Ga]PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia.
1/2017PSA levels, PSA doubling time, Gleason score and prior therapy cannot predict measured uptake of [68Ga]PSMA-HBED-CC lesion uptake in recurrent/metastatic prostate cancer.
12/2016[68Ga]PSMA-HBED-CC PET/CT to differentiate between diffuse bone metastases of prostate cancer and osteopoikilosis.
9/2016Strong [(68)Ga]PSMA-HBED-CC accumulation in non-cancerous prostate tissue surrounding a PSMA-negative prostate carcinoma recurrence.
7/2016Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.
3/2016Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.
9/2015First evidence of PSMA expression in differentiated thyroid cancer using [⁶⁸Ga]PSMA-HBED-CC PET/CT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederik A Verburg Research Topics

Disease

53Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2005
16Neoplasms (Cancer)
04/2022 - 11/2011
15Neoplasm Metastasis (Metastasis)
06/2022 - 04/2009
7Prostatic Neoplasms (Prostate Cancer)
01/2017 - 09/2014
5Papillary Thyroid Cancer
01/2021 - 12/2007
5Thyroid Nodule (Nodule, Thyroid)
01/2019 - 07/2013
5Lymphatic Metastasis
04/2017 - 12/2007
4Hyperthyroidism
01/2022 - 07/2007
4follicular Thyroid cancer
08/2021 - 06/2019
4Carcinoma (Carcinomatosis)
09/2016 - 04/2009
3Meningioma (Meningiomas)
02/2019 - 06/2012
3Hypothyroidism
11/2014 - 08/2011
2Graves Disease (Basedow Disease)
07/2021 - 11/2014
2Disease Progression
05/2018 - 08/2015
2Thyroid Diseases (Thyroid Disease)
01/2017 - 12/2016
2Body Weight (Weight, Body)
04/2011 - 08/2009
2Follicular Adenocarcinoma
08/2009 - 04/2009
1Adenoma (Adenomas)
06/2022
1Adenocarcinoma
01/2022
1Melanoma (Melanoma, Malignant)
12/2021
1Herpes Simplex
12/2021
1Pituitary Neoplasms (Pituitary Adenoma)
12/2021
1Calcinosis
02/2021
1Alveolar Rhabdomyosarcoma
03/2020
1Sarcoma (Soft Tissue Sarcoma)
03/2020
1Ganglion Cysts (Ganglion)
04/2017
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2017
1Osteopoikilosis
12/2016
1Anus Neoplasms (Anal Cancer)
08/2016

Drug/Important Bio-Agent (IBA)

15ThyroglobulinFDA Link
01/2022 - 01/2005
7RacivirIBA
08/2021 - 04/2009
7IodineIBA
07/2021 - 11/2011
7N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
04/2017 - 09/2015
6Iodine-131IBA
09/2019 - 12/2007
5Radioisotopes (Radionuclides)IBA
04/2022 - 06/2012
5AntibodiesIBA
01/2022 - 10/2012
5Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2021 - 09/2011
4RadiopharmaceuticalsIBA
01/2022 - 07/2007
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2021 - 05/2012
4Thyroid HormonesIBA
03/2021 - 08/2011
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022 - 08/2012
3Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2021 - 08/2009
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020 - 08/2012
3Peptide Receptors (Peptide Receptor)IBA
01/2017 - 06/2012
2Tyrosine Kinase InhibitorsIBA
03/2021 - 05/2018
2Sorafenib (BAY 43-9006)FDA Link
03/2021 - 05/2018
2Thyroxine (Levothyroxine)FDA LinkGeneric
01/2021 - 04/2012
2ProcalcitoninIBA
01/2021 - 07/2013
2Dihydroxyphenylalanine (Dopa)IBA
01/2020 - 03/2010
2AutoantibodiesIBA
01/2019 - 10/2012
2MicroRNAs (MicroRNA)IBA
07/2018 - 05/2018
2sodium-iodide symporter (sodium iodide symporter)IBA
07/2018 - 05/2018
2AZD 6244IBA
07/2018 - 05/2018
2Indicators and Reagents (Reagents)IBA
12/2014 - 02/2014
2Pentagastrin (Peptavlon)FDA Link
07/2013 - 08/2009
2Thyrotropin AlfaFDA LinkGeneric
09/2011 - 08/2011
2fluorodopa F 18IBA
05/2010 - 03/2010
1AlbuminsIBA
06/2022
1Alkaline PhosphataseIBA
06/2022
1Lutetium-177IBA
01/2022
1LigandsIBA
01/2022
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
01/2022
1Growth Hormone (Somatotropin)IBA
12/2021
1talimogene laherparepvecIBA
12/2021
1(18F)fluoroethyltyrosineIBA
12/2021
1lenvatinibIBA
03/2021
1ORALIT (ORS)IBA
02/2021
1SolutionsIBA
01/2021
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2021
1hypericinIBA
03/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2020
1Photosensitizing Agents (Photosensitizers)IBA
03/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2020
1Gallium-68IBA
01/2020
1Antithyroid Agents (Antithyroid Drugs)IBA
01/2020
1Fluorine-18IBA
01/2020
1A-factor (Streptomyces)IBA
02/2019
1gallium Ga 68 dotatateIBA
02/2019
1Therapeutic UsesIBA
01/2019
12'-deoxyguanosine 5'-phosphate (dGMP)IBA
08/2018
1Mitogen-Activated Protein KinasesIBA
07/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2018
1Histone Deacetylase InhibitorsIBA
05/2018
1prolinedithiocarbamate (PDTC)IBA
05/2018
1PanobinostatIBA
05/2018
1AndrogensIBA
01/2017
1AntigensIBA
12/2016
1gallium 68 PSMA-11IBA
12/2016
1fluoroethylcholineIBA
07/2016

Therapy/Procedure

38Therapeutics
01/2022 - 01/2005
8Radiotherapy
03/2020 - 06/2012
5Thyroidectomy
01/2019 - 09/2008
2Drug Therapy (Chemotherapy)
01/2017 - 08/2016
1Parathyroidectomy
06/2022
1Immunotherapy
12/2021
1Photochemotherapy (Photodynamic Therapy)
03/2020
1Combined Modality Therapy
05/2018
1Castration
12/2016
1Chemoradiotherapy
08/2016
1Lymph Node Excision (Lymph Node Dissection)
07/2016